Physician profile
Connesuala Powers
NPI 1043772932
$3,284.85
in general payments reported to CMS, 2019-2025
23 companies · $64.20 in 2025
The $64.20 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,539 · 2022: $1,682 · 2025: $64.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $64.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $64.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $1,224.54 | 2022 | |
| Abbvie INC. | $809.83 | 2021-2022 | |
| Novo Nordisk INC | $252.51 | 2021-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $152.16 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $144.17 | 2022 | |
| Lilly USA, LLC | $132.41 | 2021 | |
| Mannkind Corporation | $122.19 | 2021 | |
| Amarin Pharma, INC. | $65.94 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.36 | 2021 | |
| Amgen INC. | $47.09 | 2021 | |
| Antares Pharma, INC. | $39.62 | 2025 | Xyosted |
| Glaxosmithkline, LLC. | $37.23 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $31.49 | 2021 | |
| Insulet Corporation | $28.38 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $22.93 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $18.93 | 2021 | |
| Astellas Pharma US INC | $18.01 | 2021 | |
| Lundbeck LLC | $16.59 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $15.65 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.08 | 2021 | |
| Pfizer INC. | $13.56 | 2021 | |
| Radius Health, INC. | $13.15 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connesuala Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.